Sun-Ah You

Title: Sun-Ah You: Innovator in Protein Engineering

Introduction

Sun-Ah You is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of protein engineering, particularly in the development of innovative pharmaceutical compositions. With a total of 2 patents, his work focuses on enhancing enzymatic activity and stability in therapeutic applications.

Latest Patents

One of Sun-Ah You's latest patents is related to hyaluronidase variants and pharmaceutical compositions comprising the same. This invention aims to increase the enzymatic activity and thermal stability of human hyaluronidase, an enzyme that hydrolyzes hyaluronic acid. The patent specifically addresses PH20 variants or fragments that include amino acid residue substitutions in the alpha-helix region and its linker region. Additionally, it involves the selective cleavage of amino acids at the N-terminus and/or C-terminus.

Another notable patent involves growth hormone receptor antagonists and fusion proteins thereof. This invention features a growth hormone receptor antagonist that includes a modified growth hormone variant. The growth hormone receptor antagonist is designed to exhibit strong binding potency to the growth hormone receptor and provide a long-lasting antagonistic action, potentially improving therapeutic outcomes.

Career Highlights

Sun-Ah You is currently employed at Alteogen, Inc., where he continues to advance his research in protein engineering. His work has positioned him as a key figure in the development of innovative therapeutic solutions.

Collaborations

Sun-Ah You collaborates with talented colleagues, including Soon Jae Park and Jaehyeong Ko. These partnerships enhance the research environment and contribute to the success of their projects.

Conclusion

Sun-Ah You's contributions to protein engineering and his innovative patents reflect his dedication to advancing medical science. His work at Alteogen, Inc. continues to pave the way for new therapeutic possibilities.